Global Medical Morphine Market 2023-2030

    In Stock

    Coming Soon




    Strong opiate morphine is naturally present in opium, a dark-brown substance found in poppies. It is mostly used to treat pain, but it is also frequently consumed recreationally or used to create other illegal opioids.


    Morphine can be given orally, sublingually, inhaled, injected into a muscle, injected under the skin, intravenously, into the area around the spinal cord, transdermally, or as a rectal suppository. It causes analgesia and modifies perception and emotional reaction to pain by acting directly on the central nervous system.


    With repeated use, tolerance and reliance could develop on both a physical and psychological level. It is frequently used for pain from myocardial infarction, kidney stones, and labour pain and can be taken for both acute and chronic pain.


    When given intravenously, the highest effect is felt after about 20 minutes, and when given orally, the maximum effect is felt after about 60 minutes.


    The duration of the effect is between 3 and 7 hours., Low blood pressure, nausea, vomiting, and decreased respiratory effort are a few morphine side effects that could be dangerous. Morphine is abuse-prone and addicting. After prolonged use, opioid withdrawal symptoms could manifest if the dose is decreased.


    Morphine frequently causes drowsiness, vomiting, and constipation as side effects. It is advised to use morphine with caution if you are pregnant or nursing because it could harm the unborn child.




    infographic: Medical Morphine Market , Medical Morphine Market Size, Medical Morphine Market Trends, Medical Morphine Market Forecast, Medical Morphine Market Risks, Medical Morphine Market Report, Medical Morphine Market Share


    The Global Medical Morphine Market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.



    A advanced morphine tablet is launched by MS-Contin for the used to treat moderate to severe pain, whether it is temporary or chronic.


    When other painkillers did not work well enough or could not be tolerated, the extended-release capsule and extended-release tablet are used to treat pain that is severe enough to require daily, round-the-clock, long-term opioid medication.


    Narcotic analgesics are a class of medications that includes morphine. To treat pain, it works on the central nervous system. The usage of morphine extended-release capsules and tablets is not advised if you just need pain relief for a brief period of time, such as after surgery.


    Avoid using this medication to treat minor pain or when non-narcotic medications work better. The treatment of occasional or “as needed” discomfort with this medication is not advised.



    •  MS-Contin
    • Kadian
    • AVINza
    • Morphabond
    •  Roxanol SR 
    • Oramorph



    1. How many Medical Morphine are manufactured per annum globally? Who are the sub-component suppliers in different regions?
    2. Cost breakup of a Global Medical Morphine and key vendor selection criteria
    3. Where is the Medical Morphine manufactured? What is the average margin per unit?
    4. Market share of Global Medical Morphine market manufacturers and their upcoming products
    5. Cost advantage for OEMs who manufacture Global Medical Morphine in-house
    6. key predictions for next 5 years in Global Medical Morphine market
    7. Average B-2-B Medical Morphine market price in all segments
    8. Latest trends in Medical Morphine market, by every market segment
    9. The market size (both volume and value) of the Medical Morphine market in 2023-2030 and every year in between?
    10. Production breakup of Medical Morphine market, by suppliers and their OEM relationship


    Sl no Topic
    1 Market Segmentation
    2 Scope of the report
    3 Abbreviations
    4 Research Methodology
    5 Executive Summary
    6 Introduction
    7 Insights from Industry stakeholders
    8 Cost breakdown of Product by sub-components and average profit margin
    9 Disruptive innovation in the Industry
    10 Technology trends in the Industry
    11 Consumer trends in the industry
    12 Recent Production Milestones
    13 Component Manufacturing in US, EU and China
    14 COVID-19 impact on overall market
    15 COVID-19 impact on Production of components
    16 COVID-19 impact on Point of sale
    17 Market Segmentation, Dynamics and Forecast by Geography, 2023-2030
    18 Market Segmentation, Dynamics and Forecast by Product Type, 2023-2030
    19 Market Segmentation, Dynamics and Forecast by Application, 2023-2030
    20 Market Segmentation, Dynamics and Forecast by End use, 2023-2030
    21 Product installation rate by OEM, 2023
    22 Incline/Decline in Average B-2-B selling price in past 5 years
    23 Competition from substitute products
    24 Gross margin and average profitability of suppliers
    25 New product development in past 12 months
    26 M&A in past 12 months
    27 Growth strategy of leading players
    28 Market share of vendors, 2023
    29 Company Profiles
    30 Unmet needs and opportunity for new suppliers
    31 Conclusion
    32 Appendix
      Your Cart
      Your cart is emptyReturn to Shop